There are more companies out there than you could ever check one by one, so you end up buying whatever a friend mentioned. Bróna Noonan says her son Donnacha was born “perfectly healthy.” In the weeks after, he started losing muscle tone and having trouble feeding. At first it looked like colic or reflux, among other things. He was 12 weeks old when he was diagnosed with spinal muscular atrophy, or SMA, a condition that wastes the muscles over time. The Irish broadcaster RTÉ reported his story in April. Now he’s four. He’s tube fed, uses a wheelchair and needs care around the clock.
Every baby born in Ireland is offered a heel prick test at three to five days old. It’s a few drops of blood from the heel. The sample goes to the national screening lab, which checks it for a short list of rare, serious conditions that can be treated if they’re caught early. When Donnacha was born, SMA wasn’t on that list. His mother has campaigned to put it there ever since. On April 13, SMA went on the list, and she called it a “monumental day.”
Why anybody screens
Ireland registered 54,125 births in 2025, the Central Statistics Office says. Each year the heel prick program finds about 130 babies with one of the conditions it tests for. That’s roughly one baby in 400. You can’t send every newborn to a specialist for a full checkup. So every baby gets the same small test for the same short list, and almost every family says yes. The Department of Health puts uptake at 99.9 percent, so nearly every baby gets tested. The specialists spend their time on the few babies the test points to.
Picking companies runs into the same problem, only the list is much longer. The exchanges tracked by the World Federation of Exchanges had 49,054 listed companies at the end of 2024. In 2025 there were 1,471 IPOs around the world, companies selling shares to the public for the first time. If you read one annual report a day, those 49,054 companies alone would take you over 130 years. A serious investor can study a few dozen companies properly in a year. So something has to decide which few dozen.
If you don’t screen, something else decides for you, like the names in the news or a tip from your brother-in-law. Those are screens too, and you never set their rules.
What a stock screener is
A stock screener does for companies what the heel prick test does for babies. It runs the same few checks on every company it covers, using the numbers those companies already reported, and hands back the ones that pass. Then you sit down and read them.
A check earns its place when it does three things. It’s calculated the same way for every company, so you can compare the answers side by side. It comes from numbers the company reported. And the result would change your mind. If you’d shrug when a company fails it, that check doesn’t belong on your list.
Let’s say you set three checks a company has to pass: sales grew last year, the business brought in more cash than it spent, and its debt is smaller than its cash. Out of thousands, maybe a few hundred come back. Make one check stricter and you’re down to 40. At one report a day, that’s about six weeks of reading. You can do six weeks, and you picked the rules that put all 40 there.
The order matters. Set your checks before you look at any company. Once you’ve seen a name and liked its story, it’s hard to judge that company by the same rules as the rest.
My screener, Bufetico, puts every company on more than 30 exchanges through six layers, one for each thing I measure. Together, those six layers are the Bufetico Filter. The first two layers tell you if a company is cheap or expensive. Then come debt, profit and cash, which tell you if the company is financially stable enough to ride out a crisis. Sales comes last, and it tells you if the company is growing. You set the bar on each layer, and a company has to pass all six to make the list. When a number can’t be measured, that layer stays gray. Bufetico doesn’t estimate it, so the company stays off the list. Prices update after every market close, and the numbers from company reports update once a month. You can do the same thing with any screener, or with a spreadsheet and some patience.
Where this breaks
A screen only finds what it’s looking for. Until April, the heel prick test didn’t check for SMA, so the test had no way to catch it. A stock screen has the same blind spot, with far less at stake. If none of your checks looks at debt, a company buried in debt passes without a word.
Every check also costs you something. Each one you add cuts more companies, good ones included. I did the same math with Hilton’s 12,000 internship applicants in what a stock screener is. Before you pick any check, it helps to write down why you’d own a company.
Bróna Noonan and the next condition
Bróna Noonan said the most important thing to come out of all this was being “even a small part of making this change for future families.” The list isn’t finished. In 2025, the National Screening Advisory Committee sent 10 more conditions to the Health Information and Quality Authority for an evidence review. That committee is the expert group that weighs what goes on the test. The first one under review is congenital adrenal hyperplasia, a condition that affects the body’s hormones. The Department of Health expects the recommendation on it to reach Ireland’s health minister before the end of 2026.
Key factsThe numbers and where they come from · 10 October 2026
- A stock screener runs the same few checks on every company it covers, using the numbers those companies already reported, and hands back the ones that pass.
- The exchanges tracked by the World Federation of Exchanges had 49,054 listed companies at the end of 2024, and there were 1,471 IPOs around the world in 2025.
- Ireland registered 54,125 births in 2025, the Central Statistics Office says. The heel prick program finds about 130 babies a year with one of its conditions, and the Department of Health puts uptake at 99.9 percent.
- On April 13, 2026, spinal muscular atrophy was added to Ireland’s heel prick test. Bróna Noonan, whose son was diagnosed with it at 12 weeks old, had campaigned for that, RTÉ reported.